VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57166676 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000335.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q57166676‏
024 ‎‡a 0000-0002-4597-4859‏ ‎‡2 orcid‏
024 ‎‡a 24554487300‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q57166676‏
100 0 ‎‡a Chi-Chuan Wang‏ ‎‡9 es‏ ‎‡9 ast‏
400 0 ‎‡a Chi-Chuan Wang‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Chi-Chuan Wang‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
400 0 ‎‡a Vương kế quyên ‏ ‎‡c Nghiên cứu giả ‏ ‎‡9 zh‏
670 ‎‡a Author's A Web-Based Clinical System for Cohort Surveillance of Specific Clinical Effectiveness and Safety Outcomes: A Cohort Study of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin‏
670 ‎‡a Author's Alternative Therapies as a Substitute for Costly Prescription Medications: Results from the 2011 National Health Interview Survey‏
670 ‎‡a Author's Antidepressants and Valvular Heart Disease: A Nested Case-Control Study in Taiwan‏
670 ‎‡a Author's Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder.‏
670 ‎‡a Author's Building an Active Medical Product Safety Surveillance System in Taiwan: Adaptation of the U.S. Sentinel System Common Data Model Structure to the National Health Insurance Research Database in Taiwan‏
670 ‎‡a Author's Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys.‏
670 ‎‡a Author's Comparative Outcome Analysis of Penicillin-Based Versus Fluoroquinolone-Based Antibiotic Therapy for Community-Acquired Pneumonia: A Nationwide Population-Based Cohort Study‏
670 ‎‡a Author's Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan‏
670 ‎‡a Author's Coverage of atypical antipsychotics among medicare drug plans in the state of washington: changes between 2007 and 2008.‏
670 ‎‡a Author's Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study.‏
670 ‎‡a Author's Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study‏
670 ‎‡a Author's National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009‏
670 ‎‡a Author's Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey.‏
670 ‎‡a Author's Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.‏
670 ‎‡a Author's Reimbursement changes and drug switching: are severe patients more affected?‏
670 ‎‡a Author's Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria‏
670 ‎‡a Author's Risk of Intracranial Hemorrhage With Concomitant Use of Antidepressants and Nonsteroidal Anti-inflammatory Drugs: A Nested Case-Control Study‏
670 ‎‡a Author's The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.‏
670 ‎‡a Author's Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapy‏
670 ‎‡a Author's Trend and pattern of herb and supplement use in the United States: results from the 2002, 2007, and 2012 national health interview surveys‏
670 ‎‡a Author's Trends in energy and macronutrient intakes by weight status over four decades.‏
909 ‎‡a (scopus) 24554487300‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000245974859‏ ‎‡9 1‏
919 ‎‡a associationbetweenlongtermbisphosphonateuseandtheriskoffractureamongwomenaged50orolderwithosteoporosis‏ ‎‡A The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.‏ ‎‡9 1‏
919 ‎‡a riskofintracranialhemorrhagewithconcomitantuseofantidepressantsandnonsteroidalantiinflammatorydrugsanestedcasecontrolstudy‏ ‎‡A Risk of Intracranial Hemorrhage With Concomitant Use of Antidepressants and Nonsteroidal Anti-inflammatory Drugs: A Nested Case-Control Study‏ ‎‡9 1‏
919 ‎‡a renoprotectiveeffectofangiotensinconvertingenzymeinhibitorsandangiotensin2receptorblockersindiabeticpatientswithproteinuria‏ ‎‡A Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria‏ ‎‡9 1‏
919 ‎‡a reimbursementchangesanddrugswitchingareseverepatientsmoreaffected‏ ‎‡A Reimbursement changes and drug switching: are severe patients more affected?‏ ‎‡9 1‏
919 ‎‡a patternsofpharmacologicaltreatmentforosteoporosisamongpatientsqualifiedforpharmacotherapyaccordingtothenationalosteoporosisfoundationguidelines‏ ‎‡A Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.‏ ‎‡9 1‏
919 ‎‡a patternsandpredictorsofantipsychoticmedicationuseamongtheuspopulationfindingsfromthemedicalexpenditurepanelsurvey‏ ‎‡A Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey.‏ ‎‡9 1‏
919 ‎‡a nationaltrendsofpsychotropicmedicationuseamongpatientsdiagnosedwithanxietydisordersresultsfrommedicalexpenditurepanelsurvey2004‏ ‎‡A National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009‏ ‎‡9 1‏
919 ‎‡a webbasedclinicalsystemforcohortsurveillanceofspecificclinicaleffectivenessandsafetyoutcomesacohortstudyofnonvitaminkantagonistoralanticoagulantsandwarfarin‏ ‎‡A A Web-Based Clinical System for Cohort Surveillance of Specific Clinical Effectiveness and Safety Outcomes: A Cohort Study of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin‏ ‎‡9 1‏
919 ‎‡a fluoroquinolonesversusβlactamβlactamaseinhibitorsinoutpatientswithchronicobstructivepulmonarydiseaseandpneumoniaanationwidepopulationbasedstudy‏ ‎‡A Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study‏ ‎‡9 1‏
919 ‎‡a effectivenessandsafetyofdifferentrivaroxabandosageregimensinpatientswithnonvalvularatrialfibrillationanationwidepopulationbasedcohortstudy‏ ‎‡A Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study.‏ ‎‡9 1‏
919 ‎‡a coverageofatypicalantipsychoticsamongmedicaredrugplansinthestateofwashingtonchangesbetween2007and‏ ‎‡A Coverage of atypical antipsychotics among medicare drug plans in the state of washington: changes between 2007 and 2008.‏ ‎‡9 1‏
919 ‎‡a costeffectivenessofthepharmacistassistedwarfarinmonitoringprogramatamedicalcenterintaiwan‏ ‎‡A Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan‏ ‎‡9 1‏
919 ‎‡a comparativeoutcomeanalysisofpenicillinbasedversusfluoroquinolonebasedantibiotictherapyforcommunityacquiredpneumoniaanationwidepopulationbasedcohortstudy‏ ‎‡A Comparative Outcome Analysis of Penicillin-Based Versus Fluoroquinolone-Based Antibiotic Therapy for Community-Acquired Pneumonia: A Nationwide Population-Based Cohort Study‏ ‎‡9 1‏
919 ‎‡a changesinherbanddietarysupplementuseintheusadultpopulationacomparisonofthe2002and2007nationalhealthinterviewsurveys‏ ‎‡A Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys.‏ ‎‡9 1‏
919 ‎‡a buildinganactivemedicalproductsafetysurveillancesystemintaiwanadaptationoftheussentinelsystemcommondatamodelstructuretothenationalhealthinsuranceresearchdatabaseintaiwan‏ ‎‡A Building an Active Medical Product Safety Surveillance System in Taiwan: Adaptation of the U.S. Sentinel System Common Data Model Structure to the National Health Insurance Research Database in Taiwan‏ ‎‡9 1‏
919 ‎‡a assessingmedicationadherenceandhealthcareutilizationandcostpatternsamonghospitaldischargedpatientswithschizoaffectivedisorder‏ ‎‡A Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder.‏ ‎‡9 1‏
919 ‎‡a antidepressantsandvalvularheartdiseaseanestedcasecontrolstudyintaiwan‏ ‎‡A Antidepressants and Valvular Heart Disease: A Nested Case-Control Study in Taiwan‏ ‎‡9 1‏
919 ‎‡a trendsinenergyandmacronutrientintakesbyweightstatusover4decades‏ ‎‡A Trends in energy and macronutrient intakes by weight status over four decades.‏ ‎‡9 1‏
919 ‎‡a trendandpatternofherbandsupplementuseintheunitedstatesresultsfromthe20022007and2012nationalhealthinterviewsurveys‏ ‎‡A Trend and pattern of herb and supplement use in the United States: results from the 2002, 2007, and 2012 national health interview surveys‏ ‎‡9 1‏
919 ‎‡a treatmentpatternscomplicationsanddiseaserelapseinarealworldpopulationofpatientswithmoderatetosevereulcerativecolitisinitiatingimmunomodulatortherapy‏ ‎‡A Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapy‏ ‎‡9 1‏
919 ‎‡a alternativetherapiesasasubstituteforcostlyprescriptionmedicationsresultsfromthe2011nationalhealthinterviewsurvey‏ ‎‡A Alternative Therapies as a Substitute for Costly Prescription Medications: Results from the 2011 National Health Interview Survey‏ ‎‡9 1‏
943 ‎‡a 200x‏ ‎‡A 2009‏ ‎‡9 2‏
996 ‎‡2 LC|n 85389040‏
996 ‎‡2 ISNI|0000000045366576‏
996 ‎‡2 ISNI|0000000063591902‏
996 ‎‡2 ISNI|0000000432129722‏
996 ‎‡2 ISNI|0000000139320018‏
996 ‎‡2 CYT|AC000208677‏
996 ‎‡2 J9U|987007461831405171‏
996 ‎‡2 LC|nr 89010067‏
996 ‎‡2 CYT|AC000208676‏
996 ‎‡2 SUDOC|136235514‏
996 ‎‡2 LC|no2014164496‏
996 ‎‡2 J9U|987007321954405171‏
996 ‎‡2 ISNI|0000000064209189‏
996 ‎‡2 LC|nr 93032975‏
996 ‎‡2 LC|n 50026612‏
996 ‎‡2 LC|nr 92014967‏
996 ‎‡2 LC|n 50026611‏
996 ‎‡2 DNB|133720772‏
996 ‎‡2 CYT|AC000189549‏
996 ‎‡2 CYT|AC000198666‏
996 ‎‡2 LNB|LNC10-000222391‏
996 ‎‡2 LC|n 82019684‏
996 ‎‡2 ISNI|0000000063389608‏
996 ‎‡2 LC|no2022107851‏
996 ‎‡2 ISNI|000000007266339X‏
996 ‎‡2 NUKAT|n 2005017357‏
996 ‎‡2 LC|n 83138594‏
996 ‎‡2 ISNI|0000000063299231‏
996 ‎‡2 CYT|AC000207028‏
996 ‎‡2 LC|nr 95043283‏
996 ‎‡2 LC|n 84033508‏
996 ‎‡2 CYT|AC000208611‏
996 ‎‡2 CYT|AC000208613‏
996 ‎‡2 CYT|AC000208612‏
996 ‎‡2 CYT|AC000208615‏
996 ‎‡2 DNB|172442419‏
996 ‎‡2 CYT|AC000208616‏
996 ‎‡2 LC|n 85105009‏
996 ‎‡2 ISNI|0000000121430614‏
996 ‎‡2 LC|n 80111068‏
996 ‎‡2 LC|nr 96029111‏
996 ‎‡2 ISNI|0000000063531846‏
996 ‎‡2 LC|n 86001788‏
996 ‎‡2 LC|nr 92020015‏
996 ‎‡2 ISNI|0000000084263000‏
996 ‎‡2 CYT|AC000354796‏
996 ‎‡2 ISNI|0000000444598251‏
996 ‎‡2 ISNI|0000000100471513‏
996 ‎‡2 ISNI|0000000044299252‏
996 ‎‡2 CYT|AC000210293‏
996 ‎‡2 LC|n 87936477‏
996 ‎‡2 CYT|AC000210040‏
996 ‎‡2 LC|n 87920581‏
996 ‎‡2 ISNI|0000000063703249‏
996 ‎‡2 LC|nr 00022226‏
996 ‎‡2 PLWABN|9811812136605606‏
996 ‎‡2 ISNI|0000000064125276‏
996 ‎‡2 LC|n 89601561‏
996 ‎‡2 ISNI|0000000064337770‏
996 ‎‡2 LC|nr 89001681‏
996 ‎‡2 ISNI|0000000064356103‏
996 ‎‡2 CYT|AC000210289‏
996 ‎‡2 LC|n 2016051115‏
996 ‎‡2 LC|n 86078526‏
996 ‎‡2 ISNI|0000000064221874‏
996 ‎‡2 LC|nr 90004045‏
996 ‎‡2 ISNI|0000000063778814‏
996 ‎‡2 ISNI|0000000117512107‏
996 ‎‡2 SUDOC|124332153‏
996 ‎‡2 DNB|141025301‏
996 ‎‡2 NII|DA06901506‏
996 ‎‡2 ISNI|000000006398022X‏
996 ‎‡2 CAOONL|ncf11891379‏
996 ‎‡2 CYT|AC000591339‏
996 ‎‡2 LC|no2012140036‏
996 ‎‡2 ISNI|0000000026784684‏
996 ‎‡2 ISNI|0000000063746329‏
996 ‎‡2 CYT|AC000591335‏
996 ‎‡2 ISNI|0000000077838355‏
996 ‎‡2 LC|n 80019484‏
996 ‎‡2 CYT|AC000591336‏
996 ‎‡2 CYT|AC000007591‏
996 ‎‡2 J9U|987007302290605171‏
996 ‎‡2 CYT|AC000591332‏
996 ‎‡2 CAOONL|ncf13800413‏
996 ‎‡2 LC|n 83056390‏
996 ‎‡2 ISNI|0000000077811064‏
996 ‎‡2 LC|nr 96000689‏
996 ‎‡2 SUDOC|156887428‏
996 ‎‡2 NII|DA01373604‏
996 ‎‡2 LC|nr 98020757‏
996 ‎‡2 J9U|987007304817105171‏
996 ‎‡2 RERO|A025265901‏
996 ‎‡2 CYT|AC000208540‏
996 ‎‡2 SUDOC|151103658‏
996 ‎‡2 LC|no2024093340‏
996 ‎‡2 ISNI|0000000047628613‏
996 ‎‡2 NTA|370916247‏
996 ‎‡2 NUKAT|n 2016234367‏
996 ‎‡2 ISNI|0000000122804841‏
996 ‎‡2 CYT|AC000209688‏
996 ‎‡2 ISNI|0000000064066325‏
996 ‎‡2 SELIBR|288218‏
996 ‎‡2 LC|n 84038254‏
996 ‎‡2 LC|n 81020328‏
996 ‎‡2 LC|no2020105852‏
996 ‎‡2 NUKAT|n 2021122362‏
996 ‎‡2 LC|n 82213486‏
996 ‎‡2 CYT|AC000209721‏
996 ‎‡2 PLWABN|9810636727705606‏
996 ‎‡2 ISNI|000000044964355X‏
996 ‎‡2 LC|nr 89004715‏
996 ‎‡2 LC|n 98045504‏
996 ‎‡2 CYT|AC000208629‏
996 ‎‡2 LC|nr 93052552‏
996 ‎‡2 ISNI|0000000063572760‏
996 ‎‡2 DNB|173748228‏
996 ‎‡2 CYT|AC000580118‏
996 ‎‡2 CYT|AC000209708‏
996 ‎‡2 CYT|AC000209709‏
996 ‎‡2 ISNI|000000006425369X‏
996 ‎‡2 CYT|AC000209705‏
996 ‎‡2 CYT|AC000209707‏
996 ‎‡2 CYT|AC000209700‏
996 ‎‡2 CYT|AC000209701‏
996 ‎‡2 ISNI|0000000026765520‏
996 ‎‡2 ISNI|0000000064186597‏
996 ‎‡2 LC|n 78048209‏
996 ‎‡2 LC|n 83123094‏
996 ‎‡2 CYT|AC000209683‏
996 ‎‡2 LC|nr 88005913‏
996 ‎‡2 LC|n 86061544‏
996 ‎‡2 LC|no2010039155‏
996 ‎‡2 LC|nr 95038569‏
996 ‎‡2 LC|n 84160460‏
996 ‎‡2 LC|nr 95002222‏
996 ‎‡2 LC|nr 98033810‏
996 ‎‡2 CYT|AC000208925‏
996 ‎‡2 SUDOC|243683243‏
996 ‎‡2 ISNI|0000000063499014‏
996 ‎‡2 SUDOC|079287751‏
996 ‎‡2 NTA|148543952‏
996 ‎‡2 ISNI|0000000107414642‏
996 ‎‡2 CYT|AC000009080‏
996 ‎‡2 DNB|1022878832‏
996 ‎‡2 DNB|136151183‏
996 ‎‡2 ISNI|0000000063731434‏
996 ‎‡2 ISNI|0000000118504547‏
996 ‎‡2 LC|n 83040234‏
996 ‎‡2 SUDOC|260571903‏
996 ‎‡2 J9U|987007443461605171‏
996 ‎‡2 SUDOC|137162456‏
996 ‎‡2 CYT|AC000000183‏
996 ‎‡2 ISNI|0000000081692299‏
996 ‎‡2 LC|n 85226681‏
996 ‎‡2 CYT|AC000000186‏
996 ‎‡2 LC|n 81092180‏
996 ‎‡2 ISNI|0000000063220431‏
996 ‎‡2 CYT|AC000577236‏
996 ‎‡2 ISNI|0000000063560428‏
996 ‎‡2 BAV|495_172166‏
996 ‎‡2 J9U|987007416100105171‏
996 ‎‡2 CYT|AC000210150‏
996 ‎‡2 LC|nr 90027499‏
996 ‎‡2 NKC|xx0304351‏
996 ‎‡2 LC|nr 91029890‏
996 ‎‡2 ISNI|0000000063461024‏
996 ‎‡2 J9U|987007319290805171‏
996 ‎‡2 ISNI|0000000078092946‏
996 ‎‡2 CYT|AC000217990‏
996 ‎‡2 BIBSYS|97001961‏
996 ‎‡2 ISNI|0000000119389798‏
996 ‎‡2 LC|n 99011096‏
996 ‎‡2 ISNI|0000000084517269‏
996 ‎‡2 DNB|138463344‏
996 ‎‡2 DNB|120722917‏
996 ‎‡2 ISNI|0000000064026366‏
996 ‎‡2 NUKAT|n 2022200967‏
996 ‎‡2 LC|n 81008953‏
996 ‎‡2 LC|no 98073972‏
996 ‎‡2 LC|n 2021022902‏
996 ‎‡2 J9U|987010000218605171‏
996 ‎‡2 NUKAT|n 00028144‏
996 ‎‡2 DNB|1148662669‏
996 ‎‡2 DNB|171759893‏
996 ‎‡2 ISNI|0000000063593174‏
996 ‎‡2 LC|n 2001021414‏
996 ‎‡2 ISNI|0000000500740508‏
996 ‎‡2 LC|n 86117684‏
996 ‎‡2 DNB|1049966597‏
996 ‎‡2 NTA|323265391‏
996 ‎‡2 LC|n 88026093‏
996 ‎‡2 LC|n 87857611‏
996 ‎‡2 ISNI|0000000063660912‏
996 ‎‡2 DNB|1143633997‏
996 ‎‡2 ISNI|0000000063965695‏
996 ‎‡2 LC|n 2004050920‏
996 ‎‡2 CYT|AC000208642‏
996 ‎‡2 DNB|1067530231‏
996 ‎‡2 CYT|AC000208641‏
996 ‎‡2 CYT|AC000208646‏
996 ‎‡2 CYT|AC000208647‏
996 ‎‡2 CYT|AC000208644‏
996 ‎‡2 CYT|AC000208645‏
996 ‎‡2 J9U|987007384243505171‏
996 ‎‡2 CYT|AC000322225‏
996 ‎‡2 CYT|AC000208649‏
996 ‎‡2 LC|n 86141708‏
996 ‎‡2 LC|no 98106912‏
996 ‎‡2 ISNI|0000000070541567‏
996 ‎‡2 J9U|987007322724905171‏
996 ‎‡2 SUDOC|181216132‏
996 ‎‡2 BIBSYS|4079898‏
996 ‎‡2 LC|no2005092401‏
996 ‎‡2 RERO|A011241346‏
996 ‎‡2 LC|n 85100064‏
996 ‎‡2 LC|n 84023824‏
996 ‎‡2 LC|n 87874862‏
996 ‎‡2 DNB|1049479297‏
996 ‎‡2 DNB|138047014‏
996 ‎‡2 SUDOC|225816148‏
996 ‎‡2 LC|n 78035430‏
996 ‎‡2 NII|DA15280727‏
996 ‎‡2 LC|n 82131997‏
996 ‎‡2 CYT|AC000373975‏
996 ‎‡2 LC|n 79000724‏
996 ‎‡2 CYT|AC000210254‏
996 ‎‡2 ISNI|0000000063744737‏
996 ‎‡2 ISNI|0000000063722722‏
996 ‎‡2 DNB|1213880890‏
996 ‎‡2 LC|nr 90006860‏
996 ‎‡2 NUKAT|n 2005146580‏
996 ‎‡2 LC|nr 94021473‏
996 ‎‡2 ISNI|0000000063524486‏
996 ‎‡2 LC|n 82238236‏
996 ‎‡2 DNB|1270755692‏
996 ‎‡2 ISNI|0000000109372239‏
996 ‎‡2 ISNI|0000000084338180‏
996 ‎‡2 NTA|364154357‏
996 ‎‡2 ISNI|000000006360446X‏
996 ‎‡2 SUDOC|183924096‏
996 ‎‡2 ISNI|0000000080109049‏
996 ‎‡2 LC|nr 99040281‏
996 ‎‡2 ISNI|0000000444608077‏
996 ‎‡2 ISNI|0000000112105035‏
996 ‎‡2 SUDOC|137538359‏
996 ‎‡2 LC|nr 91023857‏
996 ‎‡2 LC|nr 91006183‏
996 ‎‡2 ISNI|000000008347130X‏
996 ‎‡2 LC|n 86125233‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏